Type 2 Diabetes Treatment
- All
- News
- Videos
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Neonatal Diabetes Alert: Doctor Shares Breastfeeding Tips That Protect Babies
Neonatal diabetes is fundamentally different from the Type 2 diabetes that is seen in adults.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
-
What's India's Average BMI? How National Guidelines Differ From Global Norms
Indians face higher diabetes and heart risks at lower body mass index (BMI) levels than Western populations.
-
What Is Insulin Resistance? Signs And Symptoms To Watch Out For
Insulin resistance is a complex condition in which the body's cells become less responsive to the hormone insulin. It is a significant risk factor for various health issues.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Neonatal Diabetes Alert: Doctor Shares Breastfeeding Tips That Protect Babies
Neonatal diabetes is fundamentally different from the Type 2 diabetes that is seen in adults.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
-
What's India's Average BMI? How National Guidelines Differ From Global Norms
Indians face higher diabetes and heart risks at lower body mass index (BMI) levels than Western populations.
-
What Is Insulin Resistance? Signs And Symptoms To Watch Out For
Insulin resistance is a complex condition in which the body's cells become less responsive to the hormone insulin. It is a significant risk factor for various health issues.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
